Kingworld Medicines Group Ltd. (HK:1110)
:1110
Want to see HK:1110 full AI Analyst Report?
Total Valuation
Kingworld Medicines Group Ltd. has a market cap or net worth of HK$278.99M. The enterprise value is HK$405.84M.
Market CapHK$278.99M
Enterprise ValueHK$405.84M
Share Statistics
Kingworld Medicines Group Ltd. has 622,499,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding622,499,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kingworld Medicines Group Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.82%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)2.82%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee919.34K
Profits Per Employee59.09K
Employee Count972
Asset Turnover0.62
Inventory Turnover4.89
Valuation Ratios
The current PE Ratio of Kingworld Medicines Group Ltd. is 24.9. Kingworld Medicines Group Ltd.’s PEG ratio is -0.34.
PE Ratio24.9
PS Ratio0.31
PB Ratio0.44
Price to Fair Value0.44
Price to FCF4.99
Price to Operating Cash Flow2.95
PEG Ratio-0.34
Income Statement
In the last 12 months, Kingworld Medicines Group Ltd. had revenue of 893.60M and earned 10.99M in profits. Earnings per share was 0.02.
Revenue893.60M
Gross Profit241.49M
Operating Income47.85M
Pretax Income55.95M
Net Income10.99M
EBITDA73.17M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 84.56M and capital expenditures -29.64M, giving a free cash flow of 54.92M billion.
Operating Cash Flow84.56M
Free Cash Flow54.92M
Free Cash Flow per Share0.09
Dividends & Yields
Kingworld Medicines Group Ltd. pays an annual dividend of HK$0.032, resulting in a dividend yield of 5.87%
Dividend Per ShareHK$0.032
Dividend Yield5.87%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.23
52-Week Price Change-13.21%
50-Day Moving Average0.51
200-Day Moving Average0.53
Relative Strength Index (RSI)42.95
Average Volume (3m)1.11M
Important Dates
Kingworld Medicines Group Ltd. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Kingworld Medicines Group Ltd. as a current ratio of 1.09, with Debt / Equity ratio of 70.24%
Current Ratio1.09
Quick Ratio0.85
Debt to Market Cap1.54
Net Debt to EBITDA2.32
Interest Coverage Ratio3.50
Taxes
In the past 12 months, Kingworld Medicines Group Ltd. has paid 18.06M in taxes.
Income Tax18.06M
Effective Tax Rate0.32
Enterprise Valuation
Kingworld Medicines Group Ltd. EV to EBITDA ratio is 6.06, with an EV/FCF ratio of 8.07.
EV to Sales0.50
EV to EBITDA6.06
EV to Free Cash Flow8.07
EV to Operating Cash Flow5.24
Balance Sheet
Kingworld Medicines Group Ltd. has HK$274.70M in cash and marketable securities with HK$434.05M in debt, giving a net cash position of -HK$159.35M billion.
Cash & Marketable SecuritiesHK$274.70M
Total DebtHK$434.05M
Net Cash-HK$159.35M
Net Cash Per Share-HK$0.26
Tangible Book Value Per ShareHK$1.02
Margins
Gross margin is 27.01%, with operating margin of 5.35%, and net profit margin of 1.23%.
Gross Margin27.01%
Operating Margin5.35%
Pretax Margin6.26%
Net Profit Margin1.23%
EBITDA Margin8.19%
EBIT Margin5.35%
Analyst Forecast
The average price target for Kingworld Medicines Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.43%
EPS Growth Forecast-72.61%